Ampersand Capital Partners Acquires Specac, Ltd.

Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announces the acquisition of Specac Limited (“Specac”), an industry leader in the design and manufacture of spectroscopy accessories and sample prep solutions. Founded in 1971, Specac is a global leader of Fourier Transform Infrared (FTIR) accessory manufacturing with an exceptional track record of delivering cutting-edge solutions that drive progress in spectroscopic analysis while prioritizing customer excellence. Specac employs around 80 people with offices in the US and UK, supported by a global network of distributors and dealers.

Read the full article: Ampersand Capital Partners Acquires Specac, Ltd. //


Leave a Comment

Your email address will not be published.

Scroll to Top